Publications by authors named "Jeonghee Cho"

30Publications

Mechanistic insights into differential requirement of receptor dimerization for oncogenic activation of mutant EGFR and its clinical perspective.

Authors:
Jeonghee Cho

BMB Rep 2020 Mar;53(3):133-141

Department of Nanobiomedical Science, Dankook University, Cheonan 31116, Korea.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118354PMC
March 2020

Colorectal adenocarcinoma-derived EGFR mutants are oncogenic and sensitive to EGFR-targeted monoclonal antibodies, cetuximab and panitumumab.

Int J Cancer 2020 04 9;146(8):2194-2200. Epub 2019 Jul 9.

Department of Nanobiomedical Science, Dankook University, Cheonan, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32499DOI Listing
April 2020

Early emergence of de novo EGFR T790M gatekeeper mutations during erlotinib treatment in PC9 non-small cell lung cancer cells.

Biochem Biophys Res Commun 2018 09 27;503(2):710-714. Epub 2018 Jun 27.

Department of Nanobiomedical Science, Dankook University, Cheonan, 31116, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2018.06.065DOI Listing
September 2018

Autophosphorylation of the carboxyl-terminal domain is not required for oncogenic transformation by lung-cancer derived EGFR mutants.

Int J Cancer 2018 08 5;143(3):679-685. Epub 2018 Mar 5.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.31332DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033109PMC
August 2018

Exome and transcriptome sequencing identifies loss of in metastatic colorectal cancers.

Cancer Manag Res 2017 8;9:581-589. Epub 2017 Nov 8.

Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine.

View Article

Download full-text PDF

Source
https://www.dovepress.com/exome-and-transcriptome-sequencing
Publisher Site
http://dx.doi.org/10.2147/CMAR.S149002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685135PMC
November 2017

High Expression of MicroRNA-196a Indicates Poor Prognosis in Resected Pancreatic Neuroendocrine Tumor.

Medicine (Baltimore) 2015 Dec;94(50):e2224

From the Department of Internal Medicine (YSL, HWK, JCL, KHP, JK, JK, JHH); Department of Pathology (HK); Department of Surgery (YSY, HSH), Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam; Department of Internal Medicine, Keimyung University School of Medicine, Dongsan Medical Center, Daegu (YSL); Biostatistics and Clinical Epidemiology Center, Samsung Medical Center (IS); and Samsung Genome Institute, Samsung Medical Center, Seoul; Department of Nanobiomedical Science, Dankook University, Cheonan (JC).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000002224DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058906PMC
December 2015

MerTK is a novel therapeutic target in gastric cancer.

Oncotarget 2017 Nov 20;8(57):96656-96667. Epub 2015 Apr 20.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.3750DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722512PMC
November 2017

Pazopanib, a novel multitargeted kinase inhibitor, shows potent in vitro antitumor activity in gastric cancer cell lines with FGFR2 amplification.

Mol Cancer Ther 2014 Nov 23;13(11):2527-36. Epub 2014 Sep 23.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-14-0255DOI Listing
November 2014

Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerization.

Cancer Res 2013 Nov 24;73(22):6770-9. Epub 2013 Sep 24.

Authors' Affiliations: Departments of Medical Oncology and Cancer Biology; Center for Cancer Genome Discovery, Lowe Center for Thoracic Oncology, and Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; Departments of Medicine, Brigham and Women's Hospital; Departments of Biological Chemistry and Molecular Pharmacology and Pathology, Harvard Medical School, Boston, Massachusetts; Samsung Genome Institute, Samsung Medical Center, Seoul, Republic of Korea; and The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-1145DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903789PMC
November 2013

Identification of ROS1 rearrangement in gastric adenocarcinoma.

Cancer 2013 May 7;119(9):1627-35. Epub 2013 Feb 7.

Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27967DOI Listing
May 2013

Tpl2/cot signals activate ERK, JNK, and NF-kappaB in a cell-type and stimulus-specific manner.

J Biol Chem 2005 Jun 15;280(25):23748-57. Epub 2005 Apr 15.

Molecular Oncology Research Institute, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA.

View Article

Download full-text PDF

Source
http://www.jbc.org/content/280/25/23748.full.pdf
Web Search
http://www.jbc.org/lookup/doi/10.1074/jbc.M412837200
Publisher Site
http://dx.doi.org/10.1074/jbc.M412837200DOI Listing
June 2005

Tpl2 (tumor progression locus 2) phosphorylation at Thr290 is induced by lipopolysaccharide via an Ikappa-B Kinase-beta-dependent pathway and is required for Tpl2 activation by external signals.

J Biol Chem 2005 May 18;280(21):20442-8. Epub 2005 Mar 18.

Molecular Oncology Research Institute, Tufts-New England Medical Center and Tufts Cancer Center, Boston, Massachusetts 02111, USA.

View Article

Download full-text PDF

Source
http://www.jbc.org/lookup/doi/10.1074/jbc.M413554200
Publisher Site
http://dx.doi.org/10.1074/jbc.M413554200DOI Listing
May 2005

Phosphorylation at Thr-290 regulates Tpl2 binding to NF-kappaB1/p105 and Tpl2 activation and degradation by lipopolysaccharide.

Proc Natl Acad Sci U S A 2005 Feb 7;102(7):2350-5. Epub 2005 Feb 7.

Molecular Oncology Research Institute, Tufts-New England Medical Center and Tufts Cancer Center, Boston, MA 02111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0409856102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC548980PMC
February 2005

Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals.

EMBO J 2002 Sep;21(18):4831-40

Kimmel Cancer Center, Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC126277PMC
http://dx.doi.org/10.1093/emboj/cdf478DOI Listing
September 2002